SETTLEMENT AGREEMENT BETWEEN THE UNITED STATES OF AMERICA AND LEARNING CARE GROUP, INC., UNDER TITLE III OF THE ADA

Investigation

11. During the course of the investigation, the United States determined that LCG: (i)  refused to provide assistance with insulin administration (by pen or syringe) to children with Type I diabetes based on a corporate-wide policy requiring such refusal and  (ii) discontinued its prior assistance with insulin administration by pen or syringe.